Background: Different co-creation methods were used to design and prototype a new fixative device for multiple intravenous therapies with the ability to control and identify the pharmacological therapy administered to a patient. Objectives: To validate a newly created device for the reduction of complications related to the use of intravenous therapy Methods: A multidisciplinary team composed of eight professionals specializing in the field of critical care and an engineering professional in industrial design was responsible for collecting, evaluating, and materializing the ideas and needs arising from clinical practice in a device that met the standards of the same.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To reduce the risk of complications associated with the number of pharmacological errors.
Timeframe: day 1, day 7, day 14, at 6 months after placement and start of the study
To reduce complications associated with accidental catheter withdrawals.
Timeframe: day 1, day 7, day 14, at 6 months after placement and start of the study